Bustamante, Wendy Lyn C.
HRN: 16-88-74 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2022
CEFUROXIME 1.5GM (VIAL)
07/01/2022
07/08/2022
IVT
1300mg
Q8h
UTI, PCAP-B
Waiting Final Action